Century Therapeutics, Inc.
IPSC
$0.61
-$0.01-0.84%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -23.28M | -21.94M | -126.57M | -129.89M | -131.39M |
| Total Depreciation and Amortization | 13.04M | 13.30M | 13.30M | 13.54M | 13.59M |
| Total Amortization of Deferred Charges | -- | -- | -- | 0.00 | 0.00 |
| Total Other Non-Cash Items | 13.33M | 10.58M | 12.41M | 17.27M | 19.40M |
| Change in Net Operating Assets | -117.86M | -116.44M | -9.28M | -13.06M | 936.00K |
| Cash from Operations | -114.77M | -114.51M | -110.14M | -112.14M | -97.46M |
| Capital Expenditure | -142.00K | -90.00K | -154.00K | -980.00K | -5.05M |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 0.00 | 21.00K | -- |
| Cash Acquisitions | 0.00 | -9.61M | -9.61M | -9.61M | -9.61M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 130.42M | 73.57M | 57.24M | 46.05M | 15.15M |
| Cash from Investing | 130.27M | 63.87M | 47.48M | 35.48M | 497.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Common Stock | 393.00K | 57.09M | 75.17M | 75.17M | 75.19M |
| Repurchase of Common Stock | -602.00K | -602.00K | -602.00K | -356.00K | -356.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -209.00K | 56.49M | 74.56M | 74.81M | 74.84M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 15.30M | 5.85M | 11.91M | -1.85M | -22.13M |